info@pdci.ca
Newsletter Sign-Up
Login to PDCI Services
Contact Us
Navigation
Home
About Us
What We Do
Develop Effective P&R Strategies
Establish Optimal Pricing
Demonstrate Value
Achieve Timely Market Access
Our Team
Careers
Services
Case Studies
News & Events
Resources
Provincial & CDR Deadlines
Common Drug Review (CDR) Submission Deadlines and CDEC Meeting Dates
PMPRB
PMPRB CPI Adjustment Factors Allowable Price Increases
PMPRB HDAP Meeting Dates & Submission Deadlines
Links
Consultation Responses
Blog
Publications
What’s New
Home
What’s New
19
Dec
2022
PMPRB Interim Chairperson Confirms Resignation
December 19, 2022
Mélanie Bourassa Forcier, Vice-Chairperson and Acting Chairperson of the Patented Medicine Prices Review Board (PMPRB), confirmed her ...
Read More
05
Dec
2022
PMPRB’s 2021 Annual Report Shows Worrying Decline in Number of New Medicines Launched in Canada; HDAP Meeting Tentatively Scheduled for Spring 2023
December 5, 2022
Last week the Patented Medicine Prices Review Board (PMPRB) presented its 2021 Annual Report to Federal ...
Read More
05
Dec
2022
PDCI Well Wishes for Managing Director Kaitlyn Proulx
December 5, 2022
PDCI is congratulating its Managing Director, Kaitlyn Proulx, as she begins parental leave effective November ...
Read More
05
Dec
2022
CADTH Pharmaceutical Reviews Update Includes Launch of RWE Guidance Consultation
December 5, 2022
On November 10, 2022, among other procedural updates included in the CADTH Pharmaceutical Reviews Update Issue 32, CADTH published ...
Read More
Previous
1
...
3
4
5
6
7
8
9
...
96
Next